|
mFOLFOX6 Clinical Trials
10 actively recruiting trials across 3 locations
▲ +2 trials since June 2026
Also known as: 5-Fluorouracil, 5-fluorouracil, Consolidation chemotherapy, Folinic acid, Oxaliplatin, 5-fluorouracil (FU), Leucovorin +2 more
Pipeline
Phase 1: 2Phase 2: 3Phase 3: 3Phase 1/2: 2
Top Sponsors
- Zhejiang Cancer Hospital1
- TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)1
- Sun Yat-sen University1
- National Cheng-Kung University Hospital1
- Menoufia University1
Indications
- Cancer10
- Colorectal Cancer3
- CRC (Colorectal Cancer)2
- PDAC - Pancreatic Ductal Adenocarcinoma2
- Lung Cancer2
Other7 trials
Phase 1/2
Cerritos, California1 trial
Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread
The Oncology Institute of Hope and Innovation
Phase 1/2
Los Angeles, California1 trial
BBO-11818 in Adult Subjects With KRAS Mutant Cancer
The Angeles Clinic and Research Institute - West Los Angeles Office
Phase 1
Orlando, Florida1 trial
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.